cesarean scar pregnancy
Conditions
Interventions
Trial group:Lauromacrogol pretreatment was not used
Control group:Lauromacrogol pretreatment was used
Sponsors
Hangzhou Fuyang Women And Children Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 48 Years
Inclusion criteria
Inclusion criteria: 1.History of cesarean section; 2.The clinical manifestations and imaging findings were consistent with the diagnostic criteria of type ? and type ? CSP, and the postoperative pathological diagnosis was villi or embryonic tissue; 3.There was no contraindication to surgery; 4.Type ? and ? CSP were treated with hysteroscopic curettage and ultrasound-guided lauromacrogol injection combined with hysteroscopic curettage, respectively; 5.The clinical data were complete, and statistical analysis was not affected by outpatient review, wechat, short message and telephone follow-up after surgery. 6.Patients and their families were informed of the relevant surgical risks and postoperative complications before surgery, and they voluntarily participated in the study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1.Scarred uterus due to surgery other than cesarean section of the lower uterine segment; 2.Patients with severe medical or surgical diseases and hemodynamic instability; 3.Patients who switched to surgery after drug therapy failed; 4.Patients who failed to undergo curettage; 5.Postoperative follow-up was lost and clinical data were incomplete;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Beta human chorionic gonadotropin (ß-hCG);Intraoperative blood loss; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operating time;Abdominal pain;Hemoglobin change;Vaginal Bleeding;resistance index;peak systolic velocity; | — |
Countries
China
Contacts
Public ContactLei Lv
Hangzhou Fuyang Women And Children Hospital
Outcome results
None listed